ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO

Pentagamavunon-0 (PGV-0) was derived from curcumin by molecule modification which was a preeminent product of Faculty of Pharmacy GMU and developed as a new potential analgetic-antiinflammatory agent. , it was discovered that PGV-0 had a poor bioavailability due to its low solubility. Nanoparticle e...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: , DIAN PURWITA SARI, , Dr. rer. nat. Ronny Martien, M.Si.
Aineistotyyppi: Opinnäyte
Julkaistu: [Yogyakarta] : Universitas Gadjah Mada 2012
Aiheet:
ETD
_version_ 1826045770913021952
author , DIAN PURWITA SARI
, Dr. rer. nat. Ronny Martien, M.Si.,
author_facet , DIAN PURWITA SARI
, Dr. rer. nat. Ronny Martien, M.Si.,
author_sort , DIAN PURWITA SARI
collection UGM
description Pentagamavunon-0 (PGV-0) was derived from curcumin by molecule modification which was a preeminent product of Faculty of Pharmacy GMU and developed as a new potential analgetic-antiinflammatory agent. , it was discovered that PGV-0 had a poor bioavailability due to its low solubility. Nanoparticle encapsulation using chitosan was expected to increase PGV-0 solubility profile in order to gain the bioavailability by enhancing the transport through biological membrane. The aim of this research was to produce chitosan- PGV-0 nanoparticle using low viscous and medium viscous chitosan and to do an invitro study for determining the permeation force. method. The PGV-0 nanoparticle encapsulation using low viscous and medium viscous chitosan was carried out by the ionic gelation preparation was optimized by gradual production scale, 500 µL, 15 mL, and 100 mL. Chitosan-PGV-0 nanoparticle characterization included the measurement of particle size, distribution, zeta potential, morphological shape, entrapment efficiency and entrapment stability. Chitosan-PGV-0 nanoparticle permeation force was evaluated by invitro study represented by cellular uptake and diffusion test. formula The selected were NCPL (Low Viscous Chitosan 0,05%
first_indexed 2024-03-13T22:42:29Z
format Thesis
id oai:generic.eprints.org:100437
institution Universiti Gadjah Mada
last_indexed 2024-03-13T22:42:29Z
publishDate 2012
publisher [Yogyakarta] : Universitas Gadjah Mada
record_format dspace
spelling oai:generic.eprints.org:1004372016-03-04T08:46:05Z https://repository.ugm.ac.id/100437/ ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO , DIAN PURWITA SARI , Dr. rer. nat. Ronny Martien, M.Si., ETD Pentagamavunon-0 (PGV-0) was derived from curcumin by molecule modification which was a preeminent product of Faculty of Pharmacy GMU and developed as a new potential analgetic-antiinflammatory agent. , it was discovered that PGV-0 had a poor bioavailability due to its low solubility. Nanoparticle encapsulation using chitosan was expected to increase PGV-0 solubility profile in order to gain the bioavailability by enhancing the transport through biological membrane. The aim of this research was to produce chitosan- PGV-0 nanoparticle using low viscous and medium viscous chitosan and to do an invitro study for determining the permeation force. method. The PGV-0 nanoparticle encapsulation using low viscous and medium viscous chitosan was carried out by the ionic gelation preparation was optimized by gradual production scale, 500 µL, 15 mL, and 100 mL. Chitosan-PGV-0 nanoparticle characterization included the measurement of particle size, distribution, zeta potential, morphological shape, entrapment efficiency and entrapment stability. Chitosan-PGV-0 nanoparticle permeation force was evaluated by invitro study represented by cellular uptake and diffusion test. formula The selected were NCPL (Low Viscous Chitosan 0,05% [Yogyakarta] : Universitas Gadjah Mada 2012 Thesis NonPeerReviewed , DIAN PURWITA SARI and , Dr. rer. nat. Ronny Martien, M.Si., (2012) ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO. UNSPECIFIED thesis, UNSPECIFIED. http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=56374
spellingShingle ETD
, DIAN PURWITA SARI
, Dr. rer. nat. Ronny Martien, M.Si.,
ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO
title ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO
title_full ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO
title_fullStr ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO
title_full_unstemmed ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO
title_short ENKAPSULASI NANOPARTIKEL PENTAGAMAVUNON-0 DENGAN KITOSAN VISKOSITAS RENDAH DAN VISKOSITAS SEDANG SERTA EVALUASINYA MELALUI UJI TRANSPORT OBAT SECARA INVITRO
title_sort enkapsulasi nanopartikel pentagamavunon 0 dengan kitosan viskositas rendah dan viskositas sedang serta evaluasinya melalui uji transport obat secara invitro
topic ETD
work_keys_str_mv AT dianpurwitasari enkapsulasinanopartikelpentagamavunon0dengankitosanviskositasrendahdanviskositassedangsertaevaluasinyamelaluiujitransportobatsecarainvitro
AT drrernatronnymartienmsi enkapsulasinanopartikelpentagamavunon0dengankitosanviskositasrendahdanviskositassedangsertaevaluasinyamelaluiujitransportobatsecarainvitro